Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical...
Transcript of Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical...
![Page 1: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/1.jpg)
Elemental Analysis Testing by WD-XRF:
A Simplified Approach
Glenn Williams Thanh Nguyen
Rigaku Americas Corporation
![Page 2: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/2.jpg)
Why XRF? 1. Beryllium to uranium 2. Non-destructive 3. Directly analyze
solids/liquids 4. Simple sample prep 5. Short analysis time 6. Quantitative 7. Qualitative 8. High accuracy 9. High repeatability 10. Instrument stability 11. Range: ppm - 100
mass% 12. Quality control 13. Process control 14. Exploration research 15. R&D 16. Screening
![Page 3: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/3.jpg)
Elemental Composition Analysis in Materials 1. energy research 2. electronics 3. petroleum exploration 4. plastics 5. mining 6. cement 7. pharmaceuticals 8. solar panels 9. money 10. paints 11. ceramics 12. food 13. automotive 14. metals 15. alumina 16. chemicals 17. environmental 18. geological research 19. glass 20. oil 21. gasoline…
![Page 4: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/4.jpg)
XRF Pharmaceutical Applications
• Metal Catalyst Screening
• USP 232/233 (ICH Q3D) Complimentary Technique to ICP-MS
• General Elemental
• Contamination • QC specific API’s (Na, Cl, S, Ca, etc.)
![Page 5: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/5.jpg)
1.24 peV 1.24 μeV 1.24 meV 64 eV 0.124 keV 1240 keV
Wavelength
Energy
Microwaves IR UV γ-rays
1 Å = 0.1 nm = 1 x 10-10 m
x-rays hard
soft
12.4 keV
Communication Radar GPS
Radio Television Long-waves
Radio waves
0.01 Å 100 Å 500 nm 1 mm 1 Mm 1 m 1 Å
λ(Å) = 12.4
E (keV)
Electromagnetic Spectrum
![Page 6: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/6.jpg)
① Primary X-rays strike inner shell electrons. ② An inner shell electron is kicked out as a photo electron. ③ An outer shell electron transfers to fill the vacancy. ④ Fluorescent x-ray is emitted with equivalent energy difference.
K shell
L shell
M shell
Lα
Kα
X-ray tube
Fluorescent X-rays
Sample Primary X-rays Kβ
Primary X-rays 1
Fluorescent X-rays 4
3
Photo electrons
2
Generation of X-Ray Fluorescence
![Page 7: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/7.jpg)
Wavelength (WD) vs. Energy (ED) XRF
![Page 8: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/8.jpg)
WDXRF Spectrum (4.35 – 7.75 keV)
EDXRF Spectrum (4.35 – 7.75 keV)
![Page 9: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/9.jpg)
X-r
ay in
tens
ity
C1 C2 C3 C4
I1
I2
I3
I4
① Prepare standard samples, whose concentrations are known.
② Measure the standard samples ③ Perform regression calculation to
generate a calibration curve.
Concentration
NO Recalibration Needed
Quantitative Analysis
![Page 10: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/10.jpg)
USP <233> by XRF Complimentary Technique
![Page 11: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/11.jpg)
Two Approaches : - Drug substance/Excipients - Final product testing (All combined)
Testing Options
![Page 12: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/12.jpg)
PDE for 5 Gram Daily Dose
STDS Cd Pb As Hg Co V Ni
LOQ 0.4 0.4 1.2 2.4 4 8 16
0.5J 0.5 0.5 1.5 3 5 10 20
1J 1 1 3 6 10 20 40
2J 2 2 6 12 20 40 80
ULOQ 5 5 10 20 30 50 100
J: Target concentration for a 5 gram dose finished product
![Page 13: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/13.jpg)
Preparation of Solid Standards: Pressed Pellets
Certified Metal Standards Combined Standards
At 5X Target Concentration Levels
![Page 14: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/14.jpg)
1 ml added to the “ENTIRE” 5g blank powders in Disposable acrylic mix vials - Dried
Mixer/Mill
Mix Samples
Consistency
![Page 15: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/15.jpg)
Pellet in Holder
Transfer “ENTIRE” sample to die assembly
Pellet
![Page 16: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/16.jpg)
Validation Data for 5 Gram
Max Daily Dose
![Page 17: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/17.jpg)
Elements LOD (ppm)** LOQ (ppm) Target
Concentration* (ppm)
Range (ppm) Linearity (R2)
Cd 0.13 0.4 1 0.4 – 5 0.998188
Pb 0.20 0.4 1 0.4 – 5 0.999468
As 0.13 1.2 3 1.2 – 10 0.999973
Hg 0.28 2.4 6 2.4 – 20 0.996066
Co 0.71 4 10 4 – 30 0.999319
V 1.17 8 20 8 – 50 0.999755
Ni 0.59 16 40 16 – 100 0.999974
* Target concentration is based on a 5 gram dose finished product according to USP <232> for elemental impurities ** LOD may be improved further with a longer counting time
Limit of Quantitation, Range, and Linearity
![Page 18: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/18.jpg)
Sample ID (Averages Reported) Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V (ppm) Ni (ppm)
Std Solution 1 1.00 (9.0) 1.11 (5.4) 2.90 (0.7) 5.92 (4.1) 9.94 (2.6) 20.60 (4.1) 40.54 (1.6)
Spiked 1J 0.92 (1.1) 1.14 (5.1) 2.98 (1.2) 5.58 (5.7) 9.97 (2.7) 20.19 (1.1) 40.79 (1.5)
Spiked 0.8J 0.87 (2.9) 0.95 (8.2) 2.33 (2.7) 4.35 (4.8) 8.34 (4.1) 15.86 (2.5) 32.34 (0.8)
Acceptance Criteria 1 7.69 2.69 2.76 5.80 0.30 1.99 0.62
Acceptance Criteria 2 Yes Yes Yes Yes Yes Yes Yes
Three individual samples were prepared at the following concentration containing the Target elements: Spiked 0.8J, Spiked 1J, and Standard Solution 1J Values reported are averages of three replicate measurements. Numbers in ( ) are %CV Acceptance criteria – 1. The average value of the 3 replicate measurements of Spiked 1J is within ± 15% of the
average value for the 3 replicate measurements of the Standard Solution 1J. 2. The average value of the 3 replicate measurements of Spiked 0.8J < Standard Solution 1J
Detectability
![Page 19: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/19.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V (ppm) Ni (ppm)
Nominal Concentration 1.00 1.00 3.00 6.00 10.00 20.00 40.00
Accuracy - 1 1.07 1.10 2.92 5.49 9.96 21.20 39.88
Accuracy - 2 0.94 1.12 2.91 5.37 9.82 21.11 40.45
Accuracy -3 0.98 1.05 2.85 5.30 9.67 19.94 40.41
Mean (ppm) 1.00 1.09 2.89 5.39 9.82 20.75 40.25
Precision (%CV) 6.68 3.31 1.31 1.78 1.48 3.39 0.79
Accuracy (%) 100 109 96 90 98 104 101
Three individual samples were prepared at the 1J concentration containing the Target elements Acceptance criteria - Spike recovery: 70 – 150% for the mean of three replicate preparations
Precision and Accuracy
![Page 20: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/20.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V (ppm) Ni (ppm)
Repeatability-1 0.91 1.06 3.03 5.33 10.65 21.26 40.73
Repeatability-2 1.08 1.16 2.98 6.05 10.59 20.62 40.90
Repeatability-3 1.15 1.17 2.95 5.53 10.12 20.19 40.41
Repeatability-4 1.02 1.17 2.94 5.47 10.28 20.25 40.22
Repeatability-5 0.97 1.11 2.93 5.22 9.98 20.94 40.72
Repeatability-6 0.97 1.04 2.98 5.74 10.06 21.03 40.55
Mean 1.02 1.12 2.97 5.56 10.28 20.72 40.59
Std Dev 0.09 0.06 0.04 0.30 0.28 0.44 0.25
%RSD 8.52 5.17 1.23 5.40 2.74 2.10 0.61
Six individual samples were prepared at the 1J concentration containing the Target elements Acceptance criteria - %RSD ≤ 20% for each Target element
Repeatability
![Page 21: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/21.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V (ppm) Ni (ppm)
Repeatability-1 0.91 1.06 3.03 5.33 10.65 21.26 40.73
Repeatability-2 1.08 1.16 2.98 6.05 10.59 20.62 40.90
Repeatability-3 1.15 1.17 2.95 5.53 10.12 20.19 40.41
Repeatability-4 1.02 1.17 2.94 5.47 10.28 20.25 40.22
Repeatability-5 0.97 1.11 2.93 5.22 9.98 20.94 40.72
Repeatability-6 0.97 1.04 2.98 5.74 10.06 21.03 40.55
Ruggedness-1 1.03 1.02 2.98 3.94 10.33 21.49 40.33
Ruggedness-2 1.05 0.99 2.94 4.68 10.45 19.63 40.78
Ruggedness-3 0.93 0.93 3.04 4.48 9.96 19.90 40.71
Ruggedness-4 0.86 0.94 2.99 4.38 10.09 19.51 40.56
Ruggedness-5 1.06 1.01 2.99 4.46 9.92 20.14 40.26
Ruggedness-6 1.05 0.81 3.06 4.76 9.98 19.58 39.80
Mean 1.01 1.03 2.98 5.00 10.20 20.38 40.50
Std Dev 0.08 0.11 0.04 0.64 0.25 0.68 0.31
%RSD 8.07 10.59 1.40 12.84 2.49 3.34 0.76
Repeatability testing was analyzed on 01MAY15 by Analyst 1. Ruggedness testing was done by re-analyzing the same samples on 04MAY15 by Analyst 2. Acceptance criteria - %RSD ≤ 25% for each Target element
Precision - Ruggedness
![Page 22: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/22.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V (ppm) Ni (ppm)
Hg Pellet BLOD BLOD BLOD 112.09 BLOD BLOD BLOD
Cd Pellet 93.51 BLOD BLOD BLOD BLOD BLOD BLOD
Pb Pellet BLOD 103.09 BLOD BLOD BLOD BLOD BLOD
As Pellet BLOD BLOD 129.14 BLOD BLOD BLOD BLOD
Co Pellet BLOD BLOD BLOD BLOD 105.31 BLOD BLOD
V Pellet BLOD BLOD BLOD BLOD BLOD 104.82 BLOD
Ni Pellet BLOD BLOD BLOD BLOD BLOD BLOD 106.68
Each individual sample was spiked with only one element (at an approximate concentration of 100 ppm) and analyzed for all of the Target elements for interference Acceptance criteria – The procedure must be able to unequivocally assess each Target element in the presence of components that may be expected to be present, including other Target elements, and matrix components.
Specificity
![Page 23: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/23.jpg)
Pb-LA and As-KA has an overlap. Therefore, Pb-LB1 is used as the emission line for Pb while an overlap coefficient from Pb is used to correct for the As-KA emission line.
Specificity: Qualitative Heavy Scans
![Page 24: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/24.jpg)
Representative Pharmaceuticals
Cellulose-Based Method
Specific Product Methods
![Page 25: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/25.jpg)
Advantages of WDXRF (Example of Overlapping Elements)
![Page 26: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/26.jpg)
V-KB1 and Ti-KA are spectrally resolved by choosing the respective emission lines
Qualitative Heavy Scan of a Coated Tablet
![Page 27: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/27.jpg)
Peak deconvolution depicts the overlap of V-KA with Ti-KB1
Ti-KA
V-KA overlaps with Ti-KB1
Peak deconvolution of V-KA and Ti-KB1
Peak Deconvolution of V-KA and Ti-KB1
![Page 28: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/28.jpg)
Using V-KB1 emission line avoids overlapping with Ti-KB1 (titanium is usually contributed from a coated tablet). Good correlation is achieved with linearity ranging from 0 – 250 ppm.
V-KB1
R2=0.9998
Calibration Curve of V-KB1
![Page 29: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/29.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V-KB1 (ppm) Ni (ppm)
Replicate - 1 5.09 5.32 14.58 28.81 50.04 102.83 201.23
Replicate – 2 5.05 5.06 15.01 28.79 49.95 100.85 202.49
Replicate – 3 4.94 5.15 15.11 29.26 50.07 97.60 203.53
Replicate - 4 5.22 4.91 15.38 28.34 49.30 109.27 202.40
Replicate - 5 5.28 4.98 15.17 29.45 50.11 105.76 203.86
Mean (ppm) 5.12 5.08 15.05 28.93 49.89 103.26 202.7
Precision (%CV) 2.64 3.09 1.98 1.51 0.67 4.34 0.51
Accuracy (%) 102 102 100 96 100 103 101
Sample was prepared at the 1J concentration containing the Target elements spiked in Atorvastatin Concentrations were determined using a universal calibration curve with Bias Correction
Acceptance criteria - Spike recovery: 70 – 150% for the mean of three replicate preparations
Example: Atorvastin Accuracy/Precision at 1J
![Page 30: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/30.jpg)
Sample ID Cd (ppm) Pb (ppm) As (ppm) Hg (ppm) Co (ppm) V-KB1 (ppm) Ni (ppm)
Replicate - 1 2.26 2.52 7.32 16.60 25.91 54.60 100.68
Replicate – 2 2.81 2.40 8.01 17.06 25.42 55.92 101.31
Replicate – 3 2.30 2.58 7.72 17.65 25.52 51.36 101.69
Replicate - 4 2.22 2.50 7.78 17.37 25.73 54.81 101.30
Replicate - 5 2.28 2.57 7.72 16.97 26.78 49.49 101.86
Mean (ppm) 2.38 2.51 7.71 17.13 25.87 53.24 101.37
Precision (%CV) 10.33 2.90 3.25 2.33 2.08 5.06 0.45
Accuracy (%) 95 100 103 114 103 106 101
Sample was prepared at the 1J concentration containing the Target elements spiked in Atorvastatin Concentrations were determined using a universal calibration curve with Bias Correction
Acceptance criteria - Spike recovery: 70 – 150% for the mean of three replicate preparations
Example: Atorvastin Accuracy/Precision at 0.5J
![Page 31: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/31.jpg)
Pressed Pills: A More Simplified Approach
![Page 32: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/32.jpg)
Whole Tablets Analyses
Is This Possible?
![Page 33: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/33.jpg)
Making Standards - Pressing the Pills
Assemble the pill die press mold Transfer sample to die assembly
Using the other plunger, pack all sample into the die
![Page 34: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/34.jpg)
Place die assembly into Carver Press Typical settings: Press at 2tons for ~1 min for dwell time
After the pill is made, remove assembly from the Carver Press
Pressing the Pill
![Page 35: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/35.jpg)
Remove the pressed die to the side
Using a hammer, tap the pressed pill out
Pressed pill
Pour pills directly into analyzing cup Analyzing cup in sample holder
Removing the Pressed Pill
![Page 36: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/36.jpg)
Calibration Set
0 ppm 1 ppm 5 ppm 10 ppm 20 ppm
![Page 37: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/37.jpg)
Calibration Curves – Cd, Pb, As, Co, V, Ni
![Page 38: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/38.jpg)
Precision – Repeatability (Pills) Sample ID Cd (ppm) Pb (ppm) As (ppm) Co (ppm) V (ppm) Ni (ppm)
Repeatability-1 1.07 1.26 3.15 10.85 21.01 42.88
Repeatability-2 1.01 1.55 3.09 10.52 21.77 42.88
Repeatability-3 1.08 1.11 2.98 10.57 21.23 42.02
Repeatability-4 0.98 1.10 3.13 10.61 21.69 43.85
Repeatability-5 0.94 1.24 3.13 9.57 20.88 41.81
Repeatability-6 1.07 1.04 2.92 10.73 22.33 42.53
Mean 1.03 1.22 3.07 10.48 21.49 42.66
Std Dev 0.06 0.18 0.09 0.46 0.55 0.73
%RSD 5.61 15.14 3.08 4.38 2.54 1.71
Six individual samples were prepared at the 1J (5 gram dose) concentration containing the Target elements Acceptance criteria - %RSD ≤ 20% for each Target element
![Page 39: Elemental Analysis Testing by WD-XRF: A Simplified …2016/11/08 · XRF Pharmaceutical Applications • Metal Catalyst Screening • USP 232/233 (ICH Q3D) Complimentary Technique](https://reader034.fdocuments.in/reader034/viewer/2022042806/5f71cf4328806c2b0d40a5b7/html5/thumbnails/39.jpg)
Your Analysis...
Simplified